Optimizing the in vitro dissolution test conditions to simulate the fed gastrointestinal tract

C. Reppas , M. Vertzoni , N. Fotaki
6th European Intensive Course on New Forms and Routes for Administration of Drugs

2000
Optimising the in vitro conditions to simulate the release process in stomach after meals

C. Reppas , M. Vertzoni , N. Fotaki , J. B. Dressman
6th European Congress of Pharmaceutical Sciences, 2000 11

2
2000
Release of phenylpropanolamine pellets in media simulating the gastrointestinal tract

C. Reppas , N. Fotaki , J. Dressman , V. Loi
3rd Panhellenic Congress of Clinical Chemistry, 2000

2000
The USP IV apparatus for the assessment of intraluminal drug release profile from extended relase products in the fasted state

C. Reppas , N. Fotaki , A. Aivaliotis
2nd International Symposium on Scientific and Regulatory Aspects of Dissolution and Bioequivalence, 2005

2005
Biorelevant release data vs canine data for the prediction of isosorbide-5-mononitrate absorption profile from extended release products in the fasted state

C. Reppas , N. Fotaki
SOCRATES Intensive Programme of Innovative Therapeutics : from Molecules to Drugs, 2002

2002
Estimation of intragastric drug solubility in the fed state: comparison of various media with data in aspirates

A. Diakidou , M. Vertzoni , J. Dressman , C. Reppas
Biopharmaceutics & Drug Disposition 30 ( 6) 318 -325

32
2009
Application of automated flow injection analysis (FIA) to dissolution studies

M. Koupparis , P. Macheras , C. Reppas
International Journal of Pharmaceutics 20 ( 3) 325 -333

14
1984
Dissolution and in vitro permeation behaviours of dicumarol nitrofurantoin and sulfamethizole in the presence of protein

P. Macheras , C. Reppas
International Journal of Pharmaceutics 37 ( 1-2) 103 -112

8
1987
Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach

A. Diakidou , M. Vertzoni , B. Abrahamsson , J. Dressman
European Journal of Pharmaceutical Sciences 37 ( 2) 133 -140

36
2009
Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.

H. Lennernäs , L. Aarons , P. Augustijns , S. Beato
European Journal of Pharmaceutical Sciences 57 ( 1) 292 -299

123
2014
29
2006
Binding of drugs in milk: the role of casein in milk protein binding--comments on the paper by Stebler and Guentert.

P. Macheras , C. Reppas , S. Antimisiaris , T. Stebler
Pharmaceutical Research 8 ( 4) 550

1991
Viscosity modulates blood glucose response to nutrient solutions in dogs.

C. Reppas , J.B. Dressman
Diabetes Research and Clinical Practice 17 ( 2) 81 -88

25
1992
Fraction of the Bioavailable Dose Remaining in the Body at the Time of Peak Plasma Concentration in a Linear, Open, One-Compartment Model

P. Macheras , C. Reppas , M. Symillides
Journal of Pharmaceutical Sciences 81 ( 1) 110 -112

3
1992
On the Assessment of the Relative Magnitude of Rate Constants in the Linear Open One-Compartment Model

P. Macheras , M. Symillides , C. Reppas
Journal of Pharmaceutical Sciences 81 ( 12) 1231 -1233

5
1992
Optimized determination of lycopene in canine plasma using reversed-phase high-performance liquid chromatography.

M.V. Vertzoni , C. Reppas , H.A. Archontaki
Journal of Chromatography B 819 ( 1) 149 -154

10
2005
FC24 reduction of serum cholesterol concentration by HPMC

J.B. Dressman , S.Z. Swidan , C. Reppas , S.W. Tobey
European Journal of Pharmaceutical Sciences 2 106

1994